EFFECTS OF ENVIRONMENTAL-FACTORS ON THE INVITRO POTENCY OF AZITHROMYCIN

被引:39
作者
RETSEMA, JA
BRENNAN, LA
GIRARD, AE
机构
[1] Central Research Division, Pfizer Inc., Groton, 06340, CT, Eastern Point Road
关键词
D O I
10.1007/BF01975836
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The effects of media, pH, cations, serum, CO2 or anaerobic atmosphere, inoculum size and time of incubation on the in vitro potency of azithromycin were determined. The potency of azithromycin against all genera was particularly sensitive to changes in pH. The MIC for Staphylococcus aureus strains ranged from 50-mu-g/ml at pH 6 to less-than-or-equal-to 0.025-mu-g/ml at pH 8; for erythromycin the MIC change was less (1.6 to 0.05-mu-g/ml). Incubation for 18 h in 5 % CO2 or an anaerobic atmosphere (10 % CO2, 10 % H-2, 80 % N2) lowered the pH by approximately 0.8 units with gram-negative organisms and 0.4 units with gram-positive organisms. This resulted in an MIC eight times greater than the aerobic MIC. In addition, the MIC100 for azithromycin and erythromycin against Bacteroides strains growing in Wilkins-Chalgren broth fell from 3.1-mu-g/ml in the anaerobic atmosphere to 0.2 and 0.4-mu-g/ml, respectively, when using the Oxyrase enzyme system to remove oxygen. With the Oxyrase system, the pH of the medium at the MIC remained at 7.2, while it fell to 6.7 in the anaerobic gas mixture. An increase in potency for both agents was also observed with other anaerobic species when using the Oxyrase system. The addition of serum produced an increase in potency of azithromycin and erythromycin that correlated with an increase in pH during incubation, despite the use of buffered media. Adding cations to Mueller-Hinton broth resulted in increased MICs for gram-negative organisms; the highest increases observed were four-fold for Escherichia coli. The activity of control antibiotics was not affected to the same degree as that of azithromycin. Increasing the incubation period from 24 to 48 h did not change the MIC values of azithromycin for Staphylococcus aureus or Escherichia coli; however, the MBC values were lower at 48 h and equalled the MIC values. Inoculum size or manner of preparation had no significant effect on the potency of azithromycin.
引用
收藏
页码:834 / 842
页数:9
相关论文
共 25 条
[1]  
BALDWIN DR, 1990, EUR RESPIR J, V3, P886
[2]  
BANNATYNE RM, 1986, CURR THER RES CLIN E, V40, P987
[3]   INVITRO ACTIVITIES OF AZITHROMYCIN (CP-62,993), CLARITHROMYCIN (A-56268-TE-031), ERYTHROMYCIN, ROXITHROMYCIN, AND CLINDAMYCIN [J].
BARRY, AL ;
JONES, RN ;
THORNSBERRY, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (05) :752-754
[4]   SYNTHESIS, INVITRO AND INVIVO ACTIVITY OF NOVEL 9-DEOXO-9A-AZA-9A-HOMOERYTHROMYCIN A DERIVATIVES - A NEW CLASS OF MACROLIDE ANTIBIOTICS, THE AZALIDES [J].
BRIGHT, GM ;
NAGEL, AA ;
BORDNER, J ;
DESAI, KA ;
DIBRINO, JN ;
NOWAKOWSKA, J ;
VINCENT, L ;
WATROUS, RM ;
SCIAVOLINO, FC ;
ENGLISH, AR ;
RETSEMA, JA ;
ANDERSON, MR ;
BRENNAN, LA ;
BOROVOY, RJ ;
CIMOCHOWSKI, CR ;
FAIELLA, JA ;
GIRARD, AE ;
GIRARD, D ;
HERBERT, C ;
MANOUSOS, M ;
MASON, R .
JOURNAL OF ANTIBIOTICS, 1988, 41 (08) :1029-1047
[5]  
CHRISTIAN GD, 1987, ANAL CHEM, P572
[6]   THE INVITRO ACTIVITY OF CP-62,993 AGAINST HEMOPHILUS-INFLUENZAE, BRANHAMELLA-CATARRHALIS, STAPHYLOCOCCI AND STREPTOCOCCI [J].
DUNKIN, KT ;
JONES, S ;
HOWARD, AJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 21 (04) :405-411
[7]   INVITRO AND INVIVO EVALUATION OF A-56268 (TE-031), A NEW MACROLIDE [J].
FERNANDES, PB ;
BAILER, R ;
SWANSON, R ;
HANSON, CW ;
MCDONALD, E ;
RAMER, N ;
HARDY, D ;
SHIPKOWITZ, N ;
BOWER, RR ;
GADE, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (06) :865-873
[8]   COMPARISON OF THE ACID STABILITY OF AZITHROMYCIN AND ERYTHROMYCIN-A [J].
FIESE, EF ;
STEFFEN, SH .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 :39-47
[9]   THE PHARMACOKINETICS OF AZITHROMYCIN IN HUMAN SERUM AND TISSUES [J].
FOULDS, G ;
SHEPARD, RM ;
JOHNSON, RB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 :73-82
[10]   CONCENTRATIONS OF AZITHROMYCIN IN HUMAN TONSILLAR TISSUE [J].
FOULDS, G ;
CHAN, KH ;
JOHNSON, JT ;
SHEPARD, RM ;
JOHNSON, RB .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (10) :853-856